ask="4.49"
ask_size="1600"
average_daily_volume="41069"
bid="3.51"
bid_size="500"
book_value="5.08"
change="-0.01"
change_from_200_day_moving_average="-1.64"
change_from_50_day_moving_average="-1.05"
change_from_52_week_high="-8.74"
change_From_52_week_low="0.12"
change_in_percent="-0.25%"
close="4.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.39"
high_52_weeks="12.75"
last_trade_date="1/30/2017"
last_trade_price="4.01"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.00"
low_52_weeks="3.89"
market_capitalization="53.85M"
moving_average_200_day="5.65"
moving_average_50_day="5.06"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-29.06%"
percent_change_from_50_day_moving_average="-20.71%"
percent_change_from_52_week_high="-68.55%"
percent_change_from_52_week_low="+3.08%"
previous_close="4.02"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.79"
price_per_sales="10.87"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.55"
stock_exchange="NGM"
symbol="AGLE"
volume="77875"
weeks_range_52="3.89 - 12.75"
